Varicella-Zoster Virus Vaccine News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Recombinant Zoster Vaccine in Frail Individuals Recombinant Zoster Vaccine in Frail Individuals
This study evaluated the safety and efficacy of the two-dose adjuvanted recombinant zoster vaccine in frail individuals in a real-world setting.Journal of the American Geriatrics Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 11, 2021 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news

Reviewing cost-effectiveness evidence of varicella zoster virus vaccination strategies
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - February 1, 2021 Category: Drugs & Pharmacology Source Type: news

Cost effectiveness of varicella zoster virus vaccination
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2020 Category: Drugs & Pharmacology Source Type: news

Live Herpes Zoster Vaccine Fails to Provide Long-Term Protection in RA Patients on Tofacitinib Live Herpes Zoster Vaccine Fails to Provide Long-Term Protection in RA Patients on Tofacitinib
The live herpes zoster vaccine does not provide reliable long-term protection in rheumatoid arthritis (RA) patients taking tofacitinib, a recent study suggests.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 20, 2020 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news

Routine recombinant zoster vaccination recommended for allergy/immunology practices
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - February 29, 2020 Category: Drugs & Pharmacology Source Type: news

Shingles Vaccine Linked to Lower Stroke Risk Shingles Vaccine Linked to Lower Stroke Risk
New evidence suggests the Zoster Vaccine Live — administered to prevent shingles — could also reduce the risk of stroke in older adults.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 17, 2020 Category: Allergy & Immunology Tags: Neurology & Neurosurgery News Source Type: news

ASA: Herpes Zoster Vaccine May Reduce Risk for Stroke
WEDNESDAY, Feb. 12, 2020 -- Vaccination with zoster vaccine live (ZVL) is associated with a reduced risk for stroke among older adults, according to a study to be presented at the American Stroke Association International Stroke Conference, held... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 12, 2020 Category: Pharmaceuticals Source Type: news

Live Zoster Shot May Be Safe in People With Mild Immunosuppression Live Zoster Shot May Be Safe in People With Mild Immunosuppression
Live attenuated varicella zoster vaccine appears to be safe for individuals with mild immunosuppression, according to new findings.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 11, 2020 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news

Risk of herpes zoster after exposure to varicella to explore the exogenous boosting hypothesis: self controlled case series study using UK electronic healthcare data
Study of 9604 adults with both household exposure to varicella and an episode of zoster found that exposure to varicella is linked to reduction in risk of zoster by ~30% over 20 years, though findings cannot be used to justify for or against specific vaccination schedules. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 24, 2020 Category: Consumer Health News Source Type: news

Exposure to chickenpox as adult does not fully protect against shingles
Adults re-exposed to the herpes zoster virus found to be around 30% less likely to develop shingles Related items fromOnMedica GPs are dealing with growing flu rates Experts predict 'invigorated' winter flu Illness poorly managed in those with learning disability Flu activity appears to be nearing its peak Doctors can help overcome ‘vaccine hesitancy’ (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 22, 2020 Category: UK Health Source Type: news

Herpes zoster (shingles) immunisation programme 2018 to 2019: evaluation reports
These reports provide an evaluation of the shingles vaccination programme in England from 2018 to 2019. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 9, 2020 Category: Consumer Health News Source Type: news

Live Zoster Vaccine Safe in People on TNF Inhibitors Live Zoster Vaccine Safe in People on TNF Inhibitors
Patients with rheumatic diseases who are on tumor-necrosis-factor inhibitor (TNFi) therapy can safely receive the live varicella zoster vaccine, without risking vaccine-related infection, a new study suggests.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - November 26, 2019 Category: Pathology Tags: Rheumatology News Source Type: news

Herpes zoster vaccine reduces chances of shingles after stem cell transplants
This NIHR Signal says that the risk of shingles is about 10% per year in adults after autologous stem cell transplant. The evidence summary indicates that two doses of deactivated herpes zoster vaccine could be a safe and effective way to reduce that risk by about two thirds.This effect is similar to another, heat-treated, non-live vaccine. Either vaccine could reduce the pain and need for medical treatment associated with shingles, and long-lasting complications such as post-herpetic neuralgia. It ' s not yet known if people need to continue taking acyclovir as well. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 20, 2019 Category: Consumer Health News Source Type: news

New Shingles Vaccine: What You Need to Know New Shingles Vaccine: What You Need to Know
The shingles vaccine Shingrix was approved in 2017. Doctors say they are learning more about how it works, its safety risks, and how it compares to Zostavax.WebMD Health News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - November 15, 2019 Category: Infectious Diseases Tags: Family Medicine/Primary Care News Source Type: news

Shingrix for Herpes Zoster: A Review Shingrix for Herpes Zoster: A Review
This brief primer reviews the pathophysiology of herpes zoster, and summarizes the results of the clinical trials of Shingrex, the newly approved recombinant vaccine for HZ prevention.Skin Therapy Letter (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 14, 2019 Category: Allergy & Immunology Tags: Dermatology Journal Article Source Type: news